video

Webinar: Novel flow cytometry ACE-2 blocking assay

Posted: 8 January 2021 | | No comments yet

This webinar from Bio-Techne demonstrates how to use a novel in vitro flow cytometry-based assay to monitor SARS-CoV-2 binding to ACE-2.

Bio-Techne Feature Image

ACE-2 is a widely expressed receptor that is utilized by SARS-CoV-2 to enter cells. Antibody or small molecule blockade of this interaction could be a viable COVID-19 therapeutic option; however, this research is hampered by biosafety considerations. We developed an in vitro flow cytometry assay for evaluating the effectiveness of antibodies or small molecules to block SARS-CoV-2 binding. This webinar from Bio-Techne demonstrates how to use this assay to monitor SARS-CoV-2/ACE-2 interactions.











    To watch this video in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Bio-Techne

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Send this to a friend